Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

49 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
CD4(+) memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis.
Krakauer M, Sorensen PS, Sellebjerg F. Krakauer M, et al. J Neuroimmunol. 2006 Dec;181(1-2):157-64. doi: 10.1016/j.jneuroim.2006.09.006. Epub 2006 Nov 1. J Neuroimmunol. 2006. PMID: 17081623 Clinical Trial.
Endogenous interferon-β-inducible gene expression and interferon-β-treatment are associated with reduced T cell responses to myelin basic protein in multiple sclerosis.
Börnsen L, Romme Christensen J, Ratzer R, Hedegaard C, Søndergaard HB, Krakauer M, Hesse D, Nielsen CH, Sorensen PS, Sellebjerg F. Börnsen L, et al. Among authors: krakauer m. PLoS One. 2015 Mar 4;10(3):e0118830. doi: 10.1371/journal.pone.0118830. eCollection 2015. PLoS One. 2015. PMID: 25738751 Free PMC article.
Differential microRNA expression in blood in multiple sclerosis.
Søndergaard HB, Hesse D, Krakauer M, Sørensen PS, Sellebjerg F. Søndergaard HB, et al. Among authors: krakauer m. Mult Scler. 2013 Dec;19(14):1849-57. doi: 10.1177/1352458513490542. Epub 2013 Jun 17. Mult Scler. 2013. PMID: 23773985
Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.
Lund H, Krakauer M, Skimminge A, Sellebjerg F, Garde E, Siebner HR, Paulson OB, Hesse D, Hanson LG. Lund H, et al. Among authors: krakauer m. PLoS One. 2013;8(2):e56375. doi: 10.1371/journal.pone.0056375. Epub 2013 Feb 18. PLoS One. 2013. PMID: 23441184 Free PMC article.
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis.
Romme Christensen J, Börnsen L, Hesse D, Krakauer M, Sørensen PS, Søndergaard HB, Sellebjerg F. Romme Christensen J, et al. Among authors: krakauer m. J Neuroinflammation. 2012 Sep 14;9:215. doi: 10.1186/1742-2094-9-215. J Neuroinflammation. 2012. PMID: 22978757 Free PMC article.
Endogenous and recombinant type I interferons and disease activity in multiple sclerosis.
Sellebjerg F, Krakauer M, Limborg S, Hesse D, Lund H, Langkilde A, Søndergaard HB, Sørensen PS. Sellebjerg F, et al. Among authors: krakauer m. PLoS One. 2012;7(6):e35927. doi: 10.1371/journal.pone.0035927. Epub 2012 Jun 6. PLoS One. 2012. PMID: 22701554 Free PMC article.
Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production.
Hedegaard CJ, Sellebjerg F, Krakauer M, Hesse D, Bendtzen K, Nielsen CH. Hedegaard CJ, et al. Among authors: krakauer m. Mult Scler. 2011 May;17(5):567-77. doi: 10.1177/1352458510393771. Epub 2010 Dec 22. Mult Scler. 2011. PMID: 21177756
The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis.
Hedegaard CJ, Krakauer M, Bendtzen K, Sørensen PS, Sellebjerg F, Nielsen CH. Hedegaard CJ, et al. Among authors: krakauer m. Clin Immunol. 2008 Oct;129(1):80-9. doi: 10.1016/j.clim.2008.06.007. Epub 2008 Jul 23. Clin Immunol. 2008. PMID: 18653385
Cytokines and adhesion molecules in multiple sclerosis patients treated with interferon-beta1b.
Jensen J, Krakauer M, Sellebjerg F. Jensen J, et al. Among authors: krakauer m. Cytokine. 2005 Jan 7;29(1):24-30. doi: 10.1016/j.cyto.2004.09.005. Cytokine. 2005. PMID: 15579375
T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis.
Hedegaard CJ, Krakauer M, Bendtzen K, Lund H, Sellebjerg F, Nielsen CH. Hedegaard CJ, et al. Among authors: krakauer m. Immunology. 2008 Oct;125(2):161-9. doi: 10.1111/j.1365-2567.2008.02837.x. Epub 2008 Apr 4. Immunology. 2008. PMID: 18397264 Free PMC article.
49 results
Jump to page
Feedback